FDC

501.65
-8.05
(-1.58%)
ann
There are new updates from the company1 hour ago
Viewcross
right
Market Cap
8,167.37 Cr
EPS
16.39
PE Ratio
31.07
Dividend Yield
1.96 %
Industry
Healthcare
52 Week High
658.85
52 Week Low
366.25
PB Ratio
3.63
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,665.90
#1 3,99,705.21
35.18
#1 54,729.00
12.06
#1 10,980
-18.99
48.33
6,922.00
1,83,757.35
83.40
9,360.00
0.89
2,117
23.05
68.54
1,490.60
1,20,396.93
23.71
28,409.50
7.12
5,291
30.28
54.26
3,320.40
1,12,377.42
59.20
11,539.40
11.59
1,911
10.91
62.08
1,281.00
1,06,908.56
#1 19.71
33,741.20
12.36
5,725
21.14
54.13
2,416.10
99,719.39
50.14
12,207.40
19.57
1,925
-10.91
59.65
975.35
98,143.03
21.52
22,573.80
13.82
3,977
-0.19
69.99
1,919.30
87,653.56
27.52
22,192.10
#1 19.94
3,024
#1 112.49
53.08
34,030.00
72,311.37
51.77
6,409.15
10.80
1,417
27.83
64.97
1,143.60
66,420.47
19.91
31,378.10
17.55
3,366
-0.50
63.70
Forecast
Actual
Growth Rate
Revenue Growth
11.51 %
Net Income Growth
57.43 %
Cash Flow Change
42.52 %
ROE
48.77 %
ROCE
43.91 %
EBITDA Margin (Avg.)
31.20 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,149
1,266
1,468
1,505
1,640
1,813
1,956
2,270
2,343
2,468
2,714
Fixed Assets
393
675
678
674
682
674
689
705
699
680
988
Current Assets
502
523
708
722
740
927
934
1,000
1,027
1,067
1,089
Capital Work in Progress
29
20
6
13
12
24
19
105
198
262
136
Investments
273
325
491
471
585
665
790
886
806
843
375
Other Assets
454
246
293
348
360
451
458
575
640
684
0
Total Liabilities
1,149
1,266
1,468
1,505
1,640
1,813
1,956
2,270
2,343
2,468
2,714
Current Liabilities
188
163
179
212
179
246
204
272
312
311
362
Non Current Liabilities
24
20
18
18
16
19
19
42
50
60
71
Total Equity
936
1,083
1,270
1,276
1,445
1,547
1,734
1,956
1,981
2,097
2,281
Reserve & Surplus
919
1,065
1,252
1,259
1,428
1,530
1,717
1,940
1,966
2,081
2,265
Share Capital
18
18
18
18
18
17
17
17
17
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-9
4
11
1
-8
10
1
7
-14
2
Investing Activities
-89
-73
-144
21
-121
-98
-77
-145
11
-17
Operating Activities
128
174
155
150
112
250
207
162
155
221
Financing Activities
-48
-97
0
-169
-0
-142
-129
-10
-180
-202

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
69.35 %
69.35 %
69.35 %
69.36 %
69.36 %
69.50 %
69.50 %
69.50 %
69.50 %
69.50 %
69.66 %
69.66 %
69.66 %
69.66 %
69.66 %
69.66 %
69.66 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.65 %
2.51 %
2.62 %
2.67 %
2.55 %
DIIs
3.98 %
4.28 %
4.57 %
5.37 %
5.81 %
6.00 %
6.72 %
7.76 %
8.27 %
8.95 %
8.00 %
7.61 %
6.94 %
6.73 %
6.03 %
6.08 %
6.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.15 %
16.82 %
16.79 %
16.61 %
16.32 %
16.35 %
16.05 %
15.42 %
14.93 %
15.59 %
15.94 %
16.12 %
16.54 %
16.71 %
16.70 %
16.57 %
16.22 %
Others
10.52 %
9.55 %
9.29 %
8.67 %
8.51 %
8.15 %
7.73 %
7.32 %
7.31 %
5.96 %
6.40 %
6.61 %
4.22 %
4.39 %
5.00 %
5.02 %
5.20 %
No of Share Holders
0
40,327
49,335
49,889
53,582
86,503
65,318
63,172
57,012
56,717
56,928
55,341
52,377
50,634
55,400
55,228
53,880

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.25 0.00 0.00 0.8 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.9 0.00 0.00 0.28 0.00 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 463.05 456.80
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 472.20 440.05
22 Nov 2024 DIVIDEND Dividend
₹ 5.00 /share
22 Nov 2024 548.80 488.90
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 515.55 548.80
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 571.65 544.80
27 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2023 386.40 384.15

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20181 hour ago
Closure of Trading Window10 days ago
Clarification On Spurt In VolumeJun 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
Results-Financial Results For March 312025May 28, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On May 282025May 28, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2025
Board Meeting Intimation for Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Year Ended March 312025.May 22, 2025
Announcement Under Regulation 30 (LODR) - Expansion Of Liquid Oral Facility At CompanyS Sinnar PlantApr 30, 2025
Confirmation Regarding Company Not Falling Under Large Corporate Criteria As On March 31 2025Apr 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Closure of Trading WindowMar 26, 2025
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 19, 2025
Integrated Filing (Financial)Feb 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Nine Months Ended 31St December2024Feb 12, 2025
Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.Feb 07, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015Jan 31, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Intimation Of Change In Name Of CompanyS Registrar And Share Transfer Agent (RTA)Jan 02, 2025
Intimation Regarding Approval Received From US FDA For ANDA- Cefixime 400 Mg TabletsDec 18, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Announcement Under Regulation 30 (LODR) - Intimation Of Company''s New Correspondence AddressDec 12, 2024
Receipt Of Establishment Inspection Report (EIR) From US FDA With No Observations (Zero 483 S), As Closure Of Inspection Conducted At Company''s Manufacturing Facility Located At Baddi, Himachal Pradesh.Nov 13, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2024
Corporate Action-Fixation Of Record Date For 1St Interim Dividend For FY 24-25.Nov 06, 2024
Corporate Action-Board approves DividendNov 06, 2024
Unaudited ( Standalone And Consolidated) Financial Results For Quarter And Half Year Ended On September 30,2024.Nov 06, 2024
Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Half Year Ended 3Oth September 2024Nov 06, 2024
Board Meeting Intimation for Board Meeting Scheduled To Be Held On November 06,2024.Oct 28, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Closure of Trading WindowSep 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 24, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Sep 11, 2024
Update W.R.T. Composition Of Board Committees Of FDC Limited.Sep 06, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2024
Notice Of The 84Th Annual General Meeting (AGM) Of FDC LimitedSep 03, 2024
Reg. 34 (1) Annual Report.Sep 03, 2024
Intimation Of Book Closure And Cut-Off Date In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirement) Regulation 2015Sep 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2024
US-FDA Inspection At Company''s Manufacturing Facility Located At Baddi, Himachal PradeshAug 23, 2024
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 08, 2024

Technical Indicators

RSI(14)
Neutral
71.64
ATR(14)
Volatile
15.19
STOCH(9,6)
Overbought
89.16
STOCH RSI(14)
Neutral
79.47
MACD(12,26)
Bullish
2.42
ADX(14)
Strong Trend
32.30
UO(9)
Bearish
62.48
ROC(12)
Uptrend And Accelerating
11.40
WillR(14)
Overbought
-7.59

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Small Cap Fund Direct- Growth
0.00%
-4272968
-0.30%
-0.31%
ICICI Prudential Smallcap Fund Direct Plan-Growth
0.00%
-1901291
-1.01%
-0.95%
ICICI Prudential Multicap Fund Direct Plan-Growth
0.00%
-1208885
-0.35%
-0.22%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-1197689
-0.95%
-0.95%
ICICI Prudential ESG Exclusionary Strategy Fund Direct - Growth
0.00%
-559323
-1.61%
-1.58%
ICICI Prudential MNC Fund Direct - Growth
0.00%
-486581
-1.27%
-1.27%
Tata India Pharma & Healthcare Fund Direct-Growth
0.00%
-471283
-1.68%
-1.62%
Bandhan Small Cap Fund Direct-Growth
0.00%
-446288
-0.17%
-0.18%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
-153607
-0.29%
-0.31%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
-93097
-1.23%
-0.85%
ITI Pharma and Healthcare Fund Direct - Growth
0.00%
-77908
-1.55%
-1.50%
Groww Nifty Total Market Index Fund Direct - Growth
0.00%
-758
-0.01%
-0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
-697
-0.17%
-0.16%
HDFC BSE 500 Index Fund Direct - Growth
0.00%
-624
-0.01%
-0.01%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
-104
-0.01%
-0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
-100
-0.01%
-0.01%
Angel One Nifty Total Market Index Fund Direct - Growth
0.00%
-93
-0.01%
-0.01%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%